πŸ‡ΊπŸ‡Έ FDA
Patent

US 11690915

Ras inhibitors

granted A61KA61K45/06A61P

Quick answer

US patent 11690915 (Ras inhibitors) held by Revolution Medicines, Inc. expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Revolution Medicines, Inc.
Grant date
Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K45/06, A61P, A61P35/00